Related Experiment Videos

Caring for patients with acute intermittent porphyria

AACN Clinical Issues in Critical Care Nursing
|February 1, 1994
PubMed

Insights

Acute intermittent porphyria is a genetic metabolic disorder affecting heme biosynthesis. Prompt identification and management of precipitating factors are crucial for controlling severe, life-threatening attacks.

Area of Science:

  • Biochemistry
  • Genetics
  • Metabolic Disorders

Background:

  • Porphyrias are inherited metabolic disorders impacting heme biosynthesis.
  • Acute intermittent porphyria (AIP) is the most prevalent form in the U.S.
  • AIP results from a genetic defect on chromosome 11 affecting porphobilinogen deaminase.

Observation:

  • AIP attacks manifest with severe abdominal, neurological, psychiatric, and renal symptoms.
  • Symptoms can be mistaken for acute abdomen or bowel obstruction.
  • Triggers include drugs, hormonal changes, nutritional deficiencies, and infections.

Findings:

  • Management focuses on identifying and removing triggers.
  • Increasing carbohydrate intake is a key intervention.
  • Pain control and appropriate medication administration are essential.

Implications:

  • Early diagnosis and intervention can prevent severe complications.
  • Understanding AIP's triggers aids in patient management and education.
  • This research highlights the importance of a multidisciplinary approach to AIP care.

Related Concept Videos